Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Nature Reviews. Immunology|September 14, 2018
Natural killer cells and other innate lymphoid cells in cancerLaura Chiossone, Pierre-Yves Dumas, Margaux Vienne, et al.Nature Reviews. Immunology|October 14, 2018
Author Correction: Natural killer cells and other innate lymphoid cells in cancerLaura Chiossone, Pierre-Yves Dumas, Margaux Vienne, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2025
Low Dimensional Representation of Multi-Patient Flow Cytometry Datasets Using Optimal Transport for Measurable Residual Disease Detection in LeukemiaErell Gachon, Jérémie Bigot, Elsa Cazelles, et al.International Journal of Molecular Sciences|July 25, 2019
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.Cancers|February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid LeukemiaJean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.Medical Mycology|January 30, 2024
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosisXavier Brousse, Sébastien Imbert, Nahéma Issa, et al.American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.Leukemia Research|December 17, 2011
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot seriesPatrice Chevallier, Arnaud Pigneux, Nelly Robillard, et al.Journal of Cancer Research and Clinical Oncology|August 3, 2023
AML consolidation therapy: timing mattersAdrian-Manuel Reimann, Enrico Schalk, Felix Jost, et al.Pageof 7